Convalescent Plasma in Outpatients With COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

511

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

March 29, 2021

Study Completion Date

March 29, 2021

Conditions
Covid19
Interventions
BIOLOGICAL

Convalescent Plasma

SARS-CoV-2 convalescent plasma with neutralizing SARS-CoV2 antibodies titers of ≥1:160 administered via intravenous (IV) infusion.

BIOLOGICAL

Saline

Saline with multivitamin administered via intravenous (IV) infusion..

Trial Locations (53)

11203

SUNY Downstate Medical Center, Brooklyn

15213

UPMC Presbyterian Hospital, Pittsburgh

17822

Geisinger Medical Center, Danville

19140

Temple University Hospital, Philadelphia

19141

Einstein Medical Center, Philadelphia

27103

Wake Forest Baptist Medical Center, Winston-Salem

27710

Duke University Hospital, Durham

30303

Grady Memorial Hospital, Atlanta

32608

UF Health Shands Hospital, Gainesville

33136

Jackson Memorial Hospital, Miami

40202

University of Louisville Hospital, Louisville

43210

OSU Wexner Medical Center, Columbus

43608

Mercy St. Vincent Medical Center, Toledo

45219

University of Cincinnati Medical Center, Cincinnati

48073

William Beaumont Hospital, Royal Oak

48085

William Beaumont Hospital-Troy, Troy

48109

University of Michigan University Hospital, Ann Arbor

48201

Detroit Receiving Hospital, Detroit

Harper University Hospital, Detroit

48202

Henry Ford Hospital, Detroit

48235

Sinai-Grace Hospital, Detroit

49503

Spectrum Health Hospitals Butterworth Hospital, Grand Rapids

52242

University of Iowa Hospitals & Clinics, Iowa City

53226

Froedtert Hospital, Milwaukee

55101

Regions Hospital, Saint Paul

55426

HealthPartners Methodist Hospital, Saint Louis Park

60612

Rush University Medical Center, Chicago

University of Illinois Hospital, Chicago

60637

University of Chicago Medical Center, Chicago

63110

Barnes Jewish Hospital, St Louis

75235

William P. Clements Jr. University Hospital, Dallas

77030

Ben Taub General Hospital, Houston

Memorial Hermann Texas Medical Center, Houston

80045

University of Colorado Hospital, Aurora

84132

University of Utah Healthcare, Salt Lake City

85008

Valleywise Health Medical Center, Phoenix

85224

Chandler Regional Medical Center, Chandler

87106

University of New Mexico Hospital, Albuquerque

90095

Ronald Reagan UCLA Medical Center, Los Angeles

90211

Cedars-Sinai Medical Center, Los Angeles

90502

Harbor-UCLA Medical Center, Torrance

92037

UCSD Health La Jolla, La Jolla

92354

Loma Linda University Medical Center, Loma Linda

94305

Stanford University, Stanford

95817

UC Davis Medical Center, Sacramento

97239

Oregon Health & Science University Hospital, Portland

04102

Maine Medical Center, Portland

02111

Tufts Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

02462

Newton-Wellesley Hospital, Newton

01199

Baystate Medical Center, Springfield

08103

Cooper University Hospital, Camden

08901

Robert Wood Johnson University Hospital, New Brunswick

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Strategies to Innovate EmeRgENcy Care Clinical Trials Network

NETWORK

collaborator

University of Pittsburgh

OTHER

collaborator

Medical University of South Carolina

OTHER

lead

Stanford University

OTHER

NCT04355767 - Convalescent Plasma in Outpatients With COVID-19 | Biotech Hunter | Biotech Hunter